sale

cancer

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

$AVXL moving up in jumps:  no shares for sale.

SALES ARE COMING, no need to dilute anymore!

$AVXL I love it when a $100 stock is on sale for $8.

The list of indications will keep Making sales climb. .

Lock your sales with high orders next week will be a lot of fun.

“Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023”
Oh, 48 weeks! !

there could be a cure/preventative for breast cancer out there

They have a great product treating cancer with immunotherapy, peer reviewed journal

Alzheimer therapies are on the top of choices.

A drug that actually helps without any major side effects  .. and breakthrough therapy. .

$AVXL The oral Anavex 2-73 therapy met the primary and secondary endpoints of the trial, with patients receiving the therapy experiencing statistically significant improvement in cognition.

business-result

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

TG Therapeutics Inc

trading

Unbelievable how negative this stock trades against bio stocks with not much going on besides mediocre trials.

Big Loser Alert: Trading today&#39;s -7.2% move in TG THERAPEUTICS $TGTX https://wp.me/p5bLGB-iva5

↳ Why are you paying to be in a Trading Room?

action

$TGTX stock action negative this whole week.

$TGTX we&#39;re missing something here, the price action is a bit worrisome.

This price action is pathetic after holding this bag for years.

life

manipulation

It&#39;s eye opening to see the blatant manipulation.

$TGTX no real sellers here, all fake manipulation

Screw off $GS   hope they get crushed from the sec for stock manipulation  I can’t stand these fools.

Practically the only thing red today… lame 😒

$TGTX $19.00 in the red 😎 this thing sends chills down my arms.

basically what you value this stock is what you think future sales will be and i think it will be way way way above 10k starts.

$TGTX love seeing a bunch of single share sales.

$TGTX
MOST CONVENIENT- 50% faster infusion
  
SAFEST - Zero Breast Cancer Risk

MOST AFFORDABLE - By far

If TGTX was a Big Pharma Company, the medical press would be blowing it up with praise.

INFUSION TIME 3.NO BREAST CANCER ISSUES 4.

- Lowest ARR rate, no black box label, reduced brain lesions, and no reports of breast cancer.

Lowest ARR rate, no black box warning label, reduced brain lesions, and no reports of breast cancer (there are reports of breast cancer with other MS treatments, and 75% of people with MS are women).

$TGTX &quot;4 Stories of Living with Multiple Sclerosis&quot; 
Briumvi, the best and most affordable, 1HR infusion, no black box label warning, and no warning or report of causing breast cancer.

Major upgrade for patients and infusion centers

-No major health threats like breast cancer or sever liver damage like main competition

$TGTX possibly the best therapy available for MS patients that exists today!

MS is 3 times more common in women and there were no reports of breast cancer compared to the competition!

hold

$TGTX Worthwhile hold and in time will be quite profitable.

$TGTX Please hold your shares or buy more on the dip You will be very pleased with the outcome

$TGTX good day Bulls, just hold for the gold!! !

This will be huge, and the sp for BO will be massive in 2yrs if they hold out. 100+

Buy, Accumulate, Hold…it’s common sense.

$TGTX &gt; STRONG BUY = BUY/HOLD/ACCUMULATE.

market

Chartwise,  i  would think  this  is   pretty bullish;  given  crap  market. Thoughts?

$TGTX This is the rocky Biden market u all wanted.

Remember that we are ultimately at the beginning of commercialization and quite possible the safest spot to be with the current facts on our superior Briumvi treatment and best pricing for market share penetration.

$TGTX market is doing good, we doing good

$TGTX Looking strong today despite the market.

TG&#39;s Briumvi is positioned to take market share because of these advantages, including how much better it is than all other competitors.

$TGTX  
I found this on NewsBreak: The stock market is on the verge of a rare bullish trifecta that suggests big upside ahead  
https://share.newsbreak.com/2tuqqt3a

I have done plenty of research lately on the market TAM and this looks primed to move quickly once it gets rolling.

$TGTX Up 23% from the lows of pre market 3 trading days ago.

SELLAS Life Sciences Group Inc

buying

$SLS  I wont be buying anymore shares until the CEO can show is company is worth at least 150m marketcap 
 
Look at the 3 year chart be warned the CEO is a scam artist and a liar

You are better off hoarding cash vs buying into a company where the staff sells free shares and does not deserve pay raises during a economic crisis/recession.

$SLS  No one should be buying in at these prices though.

$SLS SERIOUSLY STOP FUCKING RUNNING ALL THE BUYING OTC DARK POOL!!!

This MM is refusing to honor order flow, they are refusing to move the price higher when buying comes in, they are dictating price direction and that&#39;s not their fucking job.

HOW THE FUCK DID THEY JUST FILL 24k BUYING VOLUME AND NOT A SINGLE $.01 MOVE!!!!

but buying inflow and a 5K buy order and yet POS MM will not let it fucking go!! !

application

Gfh009 is a joke and will ruin this stock until 3d meds sees fda approval for aml gps.

16/16 
In all 3 Options GPs gets FDA approval due to QOL, venclexta, onureg, oralAz - all Cr1 salvage agents are highly toxic.

This concerns me, we get the dreaded not statistically relevant ruling from the FDA.

- OUTRIGHT LIE saying THEN 52 weeks - PURE BS 
- OUTRIGHT LIE saying THEN patients need to Die 
Co is now on RECord Reiterating 80 Events, patient deaths in Q1Q2 
That is the fda green light moment.

announcement

You fucked up and shorted NCI non dilutive funding announcement and patients living longer news.

$SLS they supposedly hired a lawyer fill time and this was never announced .

The shorts feeling the pain on their announcement.

$SLS For those predicting some big announcement from Sellas on the 14th at the Regal symposium, you are going to be terribly disappointed.

investor

What a freaking smack in the face to investors.

Angelos has intentionally screwed the long term investor.

$SLS I find it arrogant that SLS would even investors were concerned about their SIVB exposure.

but after doing an offering and the way the market is, the company should be giving some communication,  otherwise you are showing you really don&#39;t care about long term  investors,  personally  I&#39;m not impressed with the way it&#39;s been handled.

$SLS This is a JOKE and the JOKE is on the real investors ☹️

$SLS SLS investors have two problems now.

If you’re an experienced investor and you buy this scam, you deserve to lose you your investment.

$SLS No one should buy  in to this unless you are new investor.

They need to communicate and support their investors and shareholders.

Scary that I bought 2 years ago 9000 shares $6.50 average price to see this today just seems like he doesn’t care at all for investors why would he?

You have surging sales, stable management team and a prime buyout target, all under $1B.

$SLS  
 
 
 
 
 
 
russian  im back bears  mba great news - 
 
trump nft on sale - 20 rubles

$SLS  
 
good news for SLS short crew - 
 
trump nft on sale at discount  -  glorious leader comrade trump will be president of the america again bigly

It also allows us to get China involved immediately which we got a 13M (unexpected), triggers 25M x 2 faster and also we get 15% of all sales faster (buy like two years).

$SLS Any news about trial halt on excellent efficiency and this will be in outer space on billions in sale potential.

Strong sales, adoption, and no increase in burn means only one thing: a higher share price.

With Keytruda being biggest cancer drug on market with $9.5 Billion in sales in 2022 and readout of GPS/Keytruda trial due out soon we can see Monumental move higher and possible buyout.

Drugmaker Merck Tops 3Q Forecasts as Keytruda Sales Jump 20%
Sales of the cancer fighter Keytruda grew 20% to more than $5.4 billion in the quarter and would have jumped 26% without the impact of foreign exchange rates, Merck said Thursday.

These patients experienced about 35% longer survival than has been reported for other second-line therapies.

* Best Available Therapy offers 6-8 months of Overall Survival  
* All pooled Regal patients, BAT and Gps combined, is 16 months.

* Best Available Therapy offers 6-8 months of Overall Survival 
* All pooled Regal patients, BAT and Gps combined, is 16 months.

Good cancer stock from what I hear in 2028.

$MRK Ovarian cancer data final P2 results are better than any other drugs by a mile.

They address a broad range of cancer indications.

$SLS Gps arm 22 months of median Overall Survival  
Best Available Therapy 8.

$SLS In addition to GPs FDA approval for AML secondary Remission patients - Gps + Keytruda/Checkpoint Inhibition is also best in class for Ovarian cancer patients.

The nation’s best means the O&#39;Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.

patient

It reported positive outcomes in pleural mesothelioma patients, including:
Improved survival: Study patients lived around 11 months.

Now phase 3 trial is showing similar results to date where patients are living longer after Galinpepimut-S up to 1.5 year longer is a breakthrough for AML patients.

- Best available treatment 6-8 months of os.

- Cured GPS patients, continue to elongate the OS curve in Gps favor every day that goes by.

$SLS NCT update, nice…
They target 140 patients in 110 investigational sites.

news

$SLS With news on its way, the confidence built in the science, fear factor is gone.

$SLS No breaking news here regarding Sellas, and its well above my understanding,

$SLS good news, at the current rate and the ridiculous prices, in about a month you can buy this company for free.

My guess is that they generated ~3m revenue through the EAP, which would be really great news.

This is a rare opportunity that you know the news is grossly good(it convinced in investor(s)) and still have the chance to load and make 50 to 100% in .month or so.

plenty of upside if there is positive news.

$SLS they picked a great day for this news. lol

So much for this offering being good news.

Positive trial data/results supported with bullish news and sentiment! 4.

PROC data are excellent compared to any combo trials.

But yesterdays paper also has me considering, if there isn&#39;t a deal with $mrk or $BMY or some other CPI BP  
--- That data is Best In Class - best in clinic, best in trial too.

Gps is doing what it has done in every single trial and its the reason Patients are living 3 fold longer than patients on best available treatments.

Treatment with GFH009 resulted in 90 to 100 percent cancer inhibition at dose levels equivalent to those already demonstrated to be safe in patients in the ongoing Phase 1 trial with no viable cancer cells at the highest dose levels.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 18, 2023

Jan, 17, 2023

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb, 3, 2023

Jan, 27, 2023

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb, 24, 2023

Jan, 24, 2023

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 18, 2023

Jan, 17, 2023

Dec, 9, 2022

Nov, 30, 2022

Nov, 25, 2022

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb, 3, 2023

Jan, 27, 2023

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb, 24, 2023

Jan, 24, 2023

Dec, 26, 2022

Dec, 24, 2022

Nov, 16, 2022

Nov, 14, 2022

Nov, 9, 2022

Oct, 31, 2022

Oct, 28, 2022